Eric Berens, MD
Vascular Surgery · Tucson, AZNPI 1679578702
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,200 of the $19,302 with a category attached, or 68.4%. Endologix LLC accounts for 72.6% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2022 at $6,032 and has fallen 85.2% since, to $892 in 2025.
Across 225 payments — averaging $85.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$14K
- Medtronic$927
- Abbott$797
- W. L. Gore & Associates, Inc.$514
- Stryker$277
- Inari Medical, Inc.$262
- plus $3K from 32 others
What the payments were for
- Consulting fees$13,20068%
- Food & beverage$6,10232%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 20 | $14,010 |
| Medtronic(2 entities) | 47 | $927 |
| Abbott | 23 | $797 |
| W. L. Gore & Associates, Inc. | 10 | $514 |
| Stryker | 5 | $277 |
| Inari Medical, Inc. | 2 | $262 |
| Boston Scientific | 10 | $214 |
| Cook Medical LLC | 10 | $203 |
| Smith+Nephew | 10 | $200 |
| Angiodynamics, Inc. | 4 | $197 |
| Penumbra, Inc. | 2 | $155 |
| Tactile Systems Technology Inc | 29 | $152 |
| Bolton Medical Inc | 1 | $141 |
| Boehringer Ingelheim | 1 | $125 |
| Cardiovascular Systems Inc. | 7 | $116 |
| Johnson & Johnson | 6 | $95 |
| Organogenesis Inc. | 4 | $86 |
| Surmodics, Inc. | 1 | $84 |
| Avinger Inc. | 4 | $82 |
| Koya Medical, Inc. | 2 | $67 |
| Silk Road Medical, Inc. | 2 | $65 |
| Imperative Care, Inc | 2 | $61 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $52 |
| Pfizer | 4 | $52 |
| Baxter Healthcare | 2 | $48 |
| Integra Lifesciences Corporation | 2 | $45 |
| Osiris Therapeutics Inc. | 2 | $34 |
| Cvrx, Inc. | 1 | $34 |
| Lemaitre Vascular, Inc. | 2 | $31 |
| Veryan Medical Incorporated | 1 | $26 |
| Amgen | 1 | $23 |
| Shape Memory Medical Inc. | 1 | $23 |
| Getinge USA Sales, LLC | 1 | $22 |
| Shockwave Medical, Inc | 1 | $21 |
| Asahi Intecc USA, Inc. | 1 | $20 |
| Siemens Medical Solutions USA, Inc. | 1 | $15 |
| Solventum Corporation | 1 | $13 |
| Bard Peripheral Vascular, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alto Abdominal Stent Graft System$5,265
- AFX2 Bifurcated Endograft System$4,200
- Ovation$2,388
- AFX$1,006
- Ovation iX Iliac Stent Graft$900
- Emboshield NAV6 system$442
- FLOWTRIEVER CATHETER, S$364
- CT THROMBECTOMY SYSTEM KIT$364
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$147
- TREO ABDOMINAL STENT-GRAFT SYSTEM$141
- Indigo System$133
- Santyl$125
- REGRANEX$125
- Oasis$125
- JARDIANCE$125
- Auryon Laser System 100-120 Vac$108
How this compares
$19,302 in reported general payments places this provider in the 75th percentile of 105 vascular surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 21 | $14,774 |
| EliquisApixaban | 12 | $13,825 |
| ClopidogrelClopidogrel Bisulfate | 61 | $445 |
| Cilostazol | 13 | $166 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $95 | $14,77421 claims |
| PfizerEliquis | $52 | $13,82512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 105 vascular surgery providers in Arizona.
Other vascular surgery in Tucson
- Joshua BaldermanTucson$135K
- John PacanowskiTucson$85K
- Joseph SabatTucson$48K
- Bernardo MendozaTucson$33K
- Federico YanquezTucson$31K
- Christopher ComptonTucson$27K
- Matthew NamannyTucson$25K
- Lauren BeliveauTucson$24K
- Layla LucasTucson$16K
- Codyjo KraemerTucson$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.